Tn5090-like class 1 integron carrying blaVIM-2 in a Pseudomonas putida strain from Portugal  by Santos, C. et al.
9. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detec-
tion of genes encoding CTX-M extended-spectrum (beta)-lactamases.
J Antimicrob Chemother 2006; 57: 154–155.
10. Arlet G, Rouveau M, Philippon A. Substitution of alanine for aspartate
at position 179 in the SHV-6 extended-spectrum b-lactamase. FEMS
Microbiol Lett 2009; 152: 163–167.
11. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Iden-
tiﬁcation of plasmids by PCR-based replicon typing. J Microbiol
Methods 2005; 63: 219–228.
12. Liu SL, Hessel A, Sanderson KE. Genomic mapping with I-Ceu I, an
intron-encoded endonuclease speciﬁc for genes for ribosomal RNA,
in Salmonella spp., Escherichia coli, and other bacteria. Proc Natl Acad
Sci USA 1993; 90: 6874–6878.
13. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally
related Escherichia coli strains expressing extended-spectrum b-lac-
tamase CTX-M-15. Emerg Infect Dis 2008; 14: 195–200.
14. Yang H, Chen S, White DG et al. Characterization of multiple-anti-
microbial-resistant Escherichia coli isolates from diseased chickens and
swine in China. J Clin Microbiol 2004; 42: 3483–3489.
15. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of
the E. coli philogenetic group. Appl EnvironMicrobiol 2000; 66: 4555–4558.
16. Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a
uropathogenic Escherichia coli clonal group by multilocus sequence
typing. J Clin Microbiol 2005; 43: 5860–5864.
17. Clermont O, Lavollay M, Vimont S et al. The CTX-M-15-producing
Escherichia coli diffusing clone belongs to a highly virulent B2 phylo-
genetic subgroup. J Antimicrob Chemother 2008; 61: 1024–1028.
18. Cagnacci S, Gualco L, Debbia E et al. European emergence of cipro-
ﬂoxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and
O15:K52:H1 causing community-acquired uncomplicated cystitis. J
Clin Microbiol 2008; 46: 2605–2612.
19. Lee MY, Choi HJ, Choi JY et al. Dissemination of ST131 and ST393
community-onset, ciproﬂoxacin-resistant Escherichia coli clones caus-
ing urinary tract infections in Korea. J Infect 2009; 2: 146–153.
20. Fabre L, Delaune` A, Espie´ E et al. Chromosomal integration of the
extended-spectrum b-lactamase gene blaCTX-M-15 in Salmonella enterica
serotype Concord from internationally adopted children. Antimicrob
Agents Chemother 2009; 53: 1808–1816.
21. Suzuki S, Shitaba N, Yamane K et al. Change in the prevalence of
extended-spectrum b-lactamase-producing Escherichia coli in Japan by
clonal spread. J Antimicrob Chemother 2009; 63: 72–79.
22. Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A. Sporadic occur-
rence of CMY-2-producing multidrug-resistant Escherichia coli of
ST-complexes 38 and 448, and ST-131 in Norway. Clin Microbiol Infect
2009; 16: 171–178.
Tn5090-like class 1 integron carrying blaVIM-2
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Abstract
Three Pseudomonas putida strains containing blaVIM-2 were iso-
lated from an inanimate surface of a female ward sanitary facility
in the Hospital Infante D. Pedro, Aveiro. A novel class 1 integ-
ron was found in strain Pp2 (aacA4/blaVIM-2/aac6¢-IIc disrupted by
an insertion sequence IS1382), and strain Pp1 was found to
carry a class 1 integron (aacA7/blaVIM-2/aacC1/aacA4), which is
described for the ﬁrst time in this species. Strain PF1 carries a
class 1 integron associated with a Tn5090-like transposon, con-
stituting the ﬁrst ﬁnding of this type of arrangement in a strain
from Portugal. This association highlights further dissemination
of blaVIM-2 in environmental hospital isolates.
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Pseudomonas putida is a Gram-negative opportunistic patho-
gen that is rarely involved in human infections [1] and is
therefore considered to be a low-grade pathogen [2–4].
Carbapenems are broad-spectrum antibiotics that are fre-
quently used in the treatment of Pseudomonas spp. infections
[3]. Consequently, the emergence of metallo-b-lactamases
(MBLs) of the IMP or VIM type among non-fermenting Gram-
negative bacteria is becoming frequent and represents an epi-
demiological risk, as these enzymes confer resistance not only
to carbapenems, but to virtually all b-lactams [4,5]. Moreover,
blaIMP and blaVIM are usually carried on integrons, in association
with aminoglycoside resistance cassettes. These mobile ele-
ments are easily spread horizontally between different species,
owing to their association with transposons or plasmids [4–7].
The blaVIM-2 gene was ﬁrst described in a Pseudomonas aeru-
ginosa [8] isolate in France. Currently, the VIM-type enzymes
constitute the second most dominant group of b-lactamases,
and have been reported in different species from 23 countries
worldwide [4,9], with the alleged ‘index’ strain being a
Portuguese P. aeruginosa isolate recovered in 1995 [10,11]. The
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presence of VIM-2 enzymes in P. putida was originally restricted
to East Asia, but recently they have been found in Latin America
(Buenos Aires) [12] and Europe (Belgium) [13].
Here we report and characterize three novel class 1 in-
tegrons found in P. putida strains from Portugal. Emphasis is
given to the integron found associated with the Tn5090-like
transposon carrying blaVIM-2, contributing to the further dis-
semination of antibiotic resistance genes.
During an infection control study in 2005, three strains of
P. putida (PFi, Pp1 and Pp2) were isolated from different sur-
faces within a female ward sanitary facility (Pp1, Pp2 and PFi
from the doorknob, sink and toilet, respectively) in the Hos-
pital Infante D. Pedro, Aveiro. The strains were identiﬁed by
16S rDNA sequencing. Antibiotic susceptibilities were deter-
mined according to the guidelines of CLSI standards [14].
MBL production was investigated by Etest MBL with imipe-
nem/imipenem + EDTA strips, according to the manufac-
turer’s instructions (AB BioMe´rieux, Solna, Sweden). The
presence of blaVIM and blaIMP was detected by PCR as previ-
ously described by Henriques et al. [15]. Only blaVIM could
be ampliﬁed; subsequently, nucleotide sequencing analysis
conﬁrmed the presence of the blaVIM-2 variant in the three
strains. In the Pp1 and Pp2 isolates, variable regions of
3800 bp and 3000 bp, respectively, were ampliﬁed, corre-
sponding to a unique and novel array of gene cassettes,
never described before in P. putida (Fig. 1).
In the Pp1 isolate, three aminoglycoside resistance genes
were found (aacA7, aacC1 and aacA4) in addition to blaVIM-2
(Fig. 1). This integron is identical to In58, originally described
in a P. aeruginosa isolate collected in 1998 in Paris [16], but it
was never described in P. putida. A similar structure was pre-
viously described in P. putida isolates from Korea; however,
the order of the two ﬁrst genes cassette is inverted, and the
third gene is different [17].
The Pp2 integron contains four genes within the variable
region (Fig. 1). The ﬁrst position is occupied by an aminogly-
coside-6¢-acetyltransferase gene (aacA4), and the second
position is occupied by the MBL gene blaVIM-2. These genes
are frequently found associated with several class 1 integ-
rons. In the third position, an aminoglycoside-6¢-N-acetyl-
transferase gene (aac(6¢)-IIc) is found, disrupted by an
insertion sequence, IS1382. This insertion sequence, when
associated with different antibiotic resistance genes, can play
an important role in their dissemination. IS1382 is composed
of a putative transposase gene (tnpA) ﬂanked by two 35-bp
inverted repeats; it has been detected in other P. putida
strains, and it is located either in a plasmid or in the chro-
mosome (AF052750 and CP000949, respectively).
Ampliﬁcation of a variable region of the integron found in the
PFi strain was unsuccessful. Therefore, the absence of qacED1/
sul1 and the presence of tniC were investigated. A variable
region of approximately 2000 bp was ampliﬁed using previously
described 5CS/tniCF primers [10], conﬁrming the presence of
tniC. This structure has never been described before in P. put-
ida. Nucleotide sequence determination revealed the presence
of blaVIM-2, followed by an open reading frame (ORF1) of
unknown function. Moreover, the predicted arrangement of
genes is different from that in previously described tniC-like in-
tegrons found in P. aeruginosa strains isolated from India, Russia,
the USA [10], Norway [18] and Taiwan [19].
intI1 blaVIM-2 ORF-1 tniC PFi
intI1 aacA7 blaVIM-2 aacA4 qacEΔ1 sul1 Pp1aacC1
blaVIM-2 tnpA aac6’-IIc qacEΔ1 sul1intI1 aacA4 Pp2
intI1 aacA7 aacC-A5 tniCblaVIM-2 dhfrB
tniCintI1 aacA7 blaVIM-2 dhfrB aacC6-II ISPa21
USA, Russia, 
Norway and 
Taiwan 
integron 
India 
integron
(a)
(b)
FIG. 1. (a) Schematic representation of Pseudomonas putida integrons reported in this study. (b) Schematic representation of Pseudomonas aeru-
ginosa tniC integrons previously found (adapted from Toleman et al. [10]). The gene cassettes are represented by boxed arrows indicating the
transcriptional orientation. A white circle represents the attI1 site, and the black circles represent the gene cassette recombination site, attC or
59-bp element.
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The blaVIM-2 gene cassette found in these integrons may
be responsible for the resistance to imipenem (‡16 mg/L)
and meropenem (‡16 mg/L) in all isolates. According to the
MIC proﬁle of the Pp1 isolate, resistance to aminoglycosides
(‡ 16 mg/L) could be due to aacA7, aacC1 and aacA4 gene
cassettes. However, in the Pp2 isolate, gentamicin (‡1 mg/L)
resistance is not observed, despite the presence of the aacA4
gene cassette, and netilmicin and tobramycin (‡1 mg/L) resis-
tance was not expected, as aac(6¢)-IIc is disrupted by tnpA,
rendering this gene inactive.
The location of the integrons was investigated by pulsed-
ﬁeld gel electrophoresis. Genomic DNA plugs were digested
by S1 (New England Biolabs, Beverly, MA, USA), separated
on 1% agarose gel with a CHEF-DRIII system (Bio-Rad,
Hemel Hempstead, UK) and hybridized with labelled 16S
rDNA and intI1 probes. The results obtained for the Pp1
and Pp2 strains suggest that both integrons are located on
plasmids (data not shown). The location of the PFi integron
could not be determined by either hybridization of pulsed-
ﬁeld gel electrophoresis S1 digests or plasmid alkaline lysis
extraction.
Recently, multiresistant P. putida isolates have been associ-
ated with difﬁcult-to-treat infections [12,13,20]. This study
demonstrates that despite the uncommon association of mul-
tiresistant P. putida with human infections within the hospital
environment, this bacterium can act as a reservoir for anti-
biotic resistance genes, highlighting its potential as an emerg-
ing nosocomial pathogen. More worrying is the fact that
these genes are located in mobile elements, e.g. blaVIM-2 in
association with the TniC-like transposon, promoting their
dissemination among other pathogens within this highly
selective environment.
The nucleotide sequences reported in this article have
been deposited in GenBank under the accession numbers
FJ237530, FJ548856 and FJ715942.
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Isolation of Mycobacterium bolletii from
human omentum after laparoscopic gastric
banding
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Abstract
Mycobacterium bolletii infection with band erosion complicating
laparoscopic gastric banding is reported. A 33-year-old man
developed right upper quadrant pain and an epigastric discharg-
ing lesion 4 weeks after revision of gastric banding for morbid
obesity. Investigation revealed band erosion with infection of the
omentum and the abdominal wall. The band was removed and
M. bolleti was isolated and identiﬁed after DNA sequence analy-
sis. To the best of our knowledge, this is the ﬁrst case in which
M. bolletii was isolated from a human omentum after complicated
gastric banding surgery.
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Bariatric surgery is currently the most efﬁcacious and endur-
ing treatment for clinically severe obesity, and the number of
bariatric surgery procedures performed has risen in recent
years. However, complications such as slippage, band ero-
sion, outlet obstruction and port problems have been fre-
quently reported. In Germany, 127 patients (1997–2004)
were analysed retrospectively after laparoscopic gastric
banding. The incidence of postoperative complications was:
gastric perforation, 3.1%; band erosion, 3.1%; band or port
leak, 2.3%; port infection, 5.3%; port dislocation, 6.9% and
pouch dilatation, 16.9% [1]. Reoperation was needed in the
case of band erosion, oesophagitis, pouch dilatation, leakage
from the balloon and oesophageal dilatation. Complications
such as massive gastrointestinal haemorrhage and circulatory
collapse as a result of erosion, recurrent small bowel
obstruction and massive pericardial effusion have been
reported rarely [2–4]. Gastric erosion is one of the late
complications of gastric banding, which requires band
removal [5–7].
The aetiology of erosion remains to be identiﬁed. With
a multidisciplinary team approach and prospective data col-
lection, it has been found that band erosion developed in
24 out of 347 patients (6.8%) who underwent gastric band-
ing [8]. Another study reported that 9.5% of 317 patients
who underwent gastric banding developed band erosion [7].
However, in a larger study where 1496 patients who
underwent gastric banding were monitored for complica-
tions, band erosion was identiﬁed in only 17 patients
(1.13%) [9]. In the present study, we report for the ﬁrst
time the isolation of Mycobacterium bolletii from human
omentum in patients who developed band erosion and
wound discharge 1 month after gastric band replacement
for morbid obesity.
A 33-year-old man presented to the emergency depart-
ment of North Shore University Hospital (New York, NY,
USA) with left upper quadrant abdominal pain and purulent
discharge from an epigastric lesion. On examination, the
patient was afebrile and vital signs were stable. Laboratory
studies, including electrolytes, blood chemistry, complete
blood indices and coagulation proﬁle, were normal. The cul-
ture of a specimen taken from the wound surface yielded
few Pseudomonas aeuroginosa and no coagulase-negative
staphylococci.
A tuberculin skin test was also negative. There was no his-
tory of tuberculosis or drug abuse.
Four years earlier, the patient had undergone gastric
band surgery as a result of morbid obesity. Revision was
performed 4 weeks before the admission. Two days after
admission, the patient underwent endoscopy and diagnostic
laparotomy, which revealed band erosion into the stomach
with band adhesion. Specimens from the infected omentum
and abdominal wall were sent for culture and antibiotic
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